Dr Allan P. Jarvis

Member of the Board of Directors


Allan joined as a member of the Board of Directors of Prokarium in early 2015 after a long and distinguished career as VP Business Development and Strategy at Wyeth and VP Corporate Development at Sanofi Pasteur amongst others. He brings more than 40 yrs of experience in vaccines and biotechnology and represents Prokarium out of Boston, USA.

Allan Jarvis is President of JBBDA, llc, a consulting organization that operates in the Vaccines and Biologicals space. Prior to this, he served for two years as a Corporate Development Advisor to Sanofi Pasteur, the Vaccine Division of Sanofi. He retired from his post as Senior Vice President, Corporate Development in 2011. During that time he oversaw Sanofi’s vaccine division’s worldwide corporate development function and was responsible for managing the company’s growth through alliances, joint-ventures, partnerships, mergers, acquisitions, and the licensing of products and technology.

Allan has built several smaller biotechnology companies as well: In 1980, Allan co-founded Damon Biotech, Inc. where he held diverse positions of increasing responsibility from Manager, Molecular Biology to Vice President, Research and Vice President Business Development. From 1990 to 1992, he worked at Abbott Laboratories, Inc., as Director, Business Development. In 1992 he joined Repligen Corp. in the dual role of Vice President, Business Planning for the parent company and Sr. Vice President, Commercial Development for its wholly owned subsidiary, Amira, Inc. Allan’s primary areas of business focus continue to include: partnering, negotiations, valuing products and technologies, strategic planning and alliance management.